
Centene (CNC) Stock Forecast & Price Target
Centene (CNC) Analyst Ratings
Bulls say
Centene is a strong and diversified company with a large presence in multiple healthcare product segments, making it well-positioned for long-term growth. Despite industry challenges, the company's focus on member retention and its strong Medicaid portfolio and Medicare Advantage presence will drive positive financial performance. With potential risks and growth drivers highlighted in the report, Centene's stock is recommended as a buy with a potential for high returns in the next 2-3 years.
Bears say
Centene is largely dependent on government-sponsored healthcare plans, which make up over 97% of its membership. With the increasing political and regulatory uncertainty surrounding these plans, as seen in the recent changes in healthcare policies and potential changes in the future, there is a high level of risk for Centene. Additionally, the company's recent sale of receivables and buyback of senior notes to improve its balance sheet may be masking underlying financial weaknesses and cash flow issues. Overall, Centene's high exposure to government programs and potential financial struggles make for a negative outlook on the stock.
This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.
Centene (CNC) Analyst Forecast & Price Prediction
Start investing in Centene (CNC)
Order type
Buy in
Order amount
Est. shares
0 shares